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Abstract
Background: The health risks of crack cocaine smoking in public settings have not been well described. We
sought to identify factors associated with public crack smoking, and assess the potential for a supervised inhalation
facility to reduce engagement in this behavior, in a setting planning to evaluate a medically supervised crack
cocaine smoking facility.
Methods: Data for this study were derived from a Canadian prospective cohort of injection drug users. Using
multivariate logistic regression we identified factors associated with smoking crack cocaine in public areas. Among
public crack smokers we then identified factors associated with willingness to use a supervised inhalation facility.
Results: Among our sample of 623 people who reported crack smoking, 61% reported recently using in public
locations. In multivariate analysis, factors independently associated with public crack smoking included: daily crack
cocaine smoking; daily heroin injection; having encounters with police; and engaging in drug dealing. In sub
analysis, 71% of public crack smokers reported willingness to use a supervised inhalation facility. Factors
independently associated with willingness include: female gender, engaging in risky pipe sharing; and having
encounters with police.
Conclusion: We found a high prevalence of public crack smoking locally, and this behavior was independently
associated with encounters with police. However, a majority of public crack smokers reported being willing to use
a supervised inhalation facility, and individuals who had recent encounters with police were more likely to report
willingness. These findings suggest that supervised inhalation facilities offer potential to reduce street-disorder and
reduce encounters with police.
Background
The use of illicit drugs in public settings, including
street, alleys and parks is both a public health and pub-
lic order concern in many urban areas [1-3]. To date,
the use of injection drugs in public settings has received
the most attention from policy-makers and public health
researchers [2,4,5]. Public injecting is known to present
problems for citizens who reside in or around areas
where public drug use is prevalent, and scientific studies
have documented that using injection drugs in public
settings can discourage safer injecting practices resulting
in many public health problems, including increased risk
for drug overdose events and HIV and other blood-
b o r n ei n f e c t i o n s[ 6 - 8 ] .A sar e s u l t ,s o m ec i t i e sh a v e
implemented supervised injection facilities which aim to
provide an alternative injecting environment that
reduces both the health risks associated with injection
drug use and the street disorder it can generate [9-13].
While supervised injection facilities have been noted to
have measurable success in achieving these public health
and public order objectives, the use of inhalable drugs,
particularly crack cocaine smoking, has been growing in
popularity in many street-based drug scenes [14-16].
In Vancouver, Canada the popularity of crack cocaine
and ease of administration through smoking has made
public crack cocaine use a common feature of the
streets in the city’s drug use epicentre, known as the
Downtown Eastside [17]. Public crack cocaine smoking
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cies responsible for maintaining public order [18]. In
addition, the health and social harms associated with
crack cocaine smoking are extensive. Compared to other
drug user populations, crack users are more likely to
engage in risky behaviors [19-21] and illegal activities
[22,23] and to experience homelessness [14] and health
problems [14,24-27], yet are less likely to access health
and social services [28]. It has also been recently docu-
mented that daily crack cocaine smokers are at a four-
fold greater risk of contracting HIV compared to their
drug using peers who smoke crack cocaine less often or
not at all [16].
Given the dramatic rise in crack cocaine smoking and
the public order and public health concerns associated
with it, the need for targeted interventions for people
who smoke crack cocaine is unambiguous. One poten-
tial intervention that is receiving increasing attention
from public health officials, health researchers and local
community groups is supervised drug consumption
facilities analogous to supervised injection sites but that
accommodate crack smoking and distribute drug con-
sumption materials specific to safer inhalation (such as
sterile crack pipes, mouthpieces, and screens) [16,29-33].
The Canadian Institutes of Health Research recently
approved funding to conduct a randomized control trial
to evaluate the impact of a supervised inhalation facility
on access to medical and social services, particularly
addiction treatment, among Vancouver-based crack
cocaine smokers [34].
Previous studies have assessed general willingness
among local drug users to use a supervised inhalation
facility [35,36]; however, these studies were not primar-
ily concerned with street disorder and therefore did not
consider the specific risks associated with smoking crack
cocaine in public areas nor did they assess willingness
to use an inhalation facility among public crack cocaine
smokers exclusively. Therefore we conducted a study
focused on public crack smokers to identify factors asso-
ciated with this practice. We also sought to assess will-
ingness to use an inhalation facility among individuals
who smoke crack cocaine in public areas to determine
the potential impact a supervised inhalation facility
might have on street disorder in Vancouver, Canada.
Methods
Data for this study was obtained from the Vancouver
I n j e c t i o nD r u gU s e r sS t u d y ,w h i c hi sa no p e np r o s p e c -
tive cohort that began enrolling people who inject drugs
(IDU) through street outreach as self-referral in May
1996. This study has been described in detail previously
[37,38]. In brief, to be eligible participants at recruit-
ment must reside in the Greater Vancouver Regional
District, have injected illicit drugs in the previous
month, and provide written informed consent. At
enrollment and on bi-annual basis participants complete
an interviewer-administered questionnaire, and after an
examination with a study nurse provide a blood sample
for serologic testing. At each study visit participants are
provided with a stipend ($20 CDN) for their time. The
study has received ethics approval from St. Paul’s Hospi-
tal and the University of British Columbia’s Research
Ethics Board. The present analyses are restricted to
those participants who reported smoking crack cocaine
in the last six months, and were seen for study follow-
up during the period of November 2008 and June 2009
as measures for one of our outcomes of interest are
available only for this sample period.
In our first analysis among crack cocaine smokers, the
outcome of interest was using drugs (non-injection) in
public areas in the last six months. As in previous ana-
lyses, public areas included city streets, parks, public
washrooms, parking lots, clubs or bars and abandoned
buildings. To characterize our outcome of interest we
ap r i o r iselected a range of socio-demographic and
behavioural variables we hypothesized might be relevant
to smoking crack cocaine in public areas. This selection
was informed by the ‘risk environment framework’ and
previous analyses among street-involved drug users
highlighting connections between social, structural and
environmental level factors and risky drug consumption
practices [14,31,39-41]. Variables included: age (per year
older); gender (female vs. male); Aboriginal Ancestry
(yes vs. no); limited access to private space, defined as
answering “no” to the question: “Do you have a private
indoor space for socializing with friends and acquain-
tances?” or reporting that the number of guests they
were allowed to have in their residence at one time was
restricted to less than three (yes vs. no); daily cocaine
injection (yes vs. no); daily heroin injection (yes vs. no);
daily crack cocaine smoking (yes vs. no); non-fatal over-
dose, self identified by participants (yes vs. no); encoun-
ters with police in the last month, defined as being
questioned, searched or stopped by police (yes vs. no);
being a victim of violence defined as being physically
assaulted (yes vs. no); sex trade involvement, defined as
exchanging sex for money, shelter, drugs or other com-
modities (yes vs. no), and participation in drug dealing
(yes vs. no). Unless otherwise stated, all drug use and
behavioural variables refert ot h ep r e v i o u ss i xm o n t h
period.
In a second analysis, we sought to assess and identify
predictors of willingness to use a supervised inhalation
room. Because we were particularly concerned with
public drug use we restricted our sample to crack
cocaine smokers that reported recently using non-
injection drugs in public areas. To measure willingness
we asked participants “If there was a safe place to
DeBeck et al. Substance Abuse Treatment, Prevention, and Policy 2011, 6:4
http://www.substanceabusepolicy.com/content/6/1/4
Page 2 of 8smoke your drugs (ventilated inhalation room), close to
where you buy or use, would you use it?”
Variables of interest for our second analysis were also
selected ap r i o r ibased on factors we hypothesized
might be associated with willingness to use an inhalation
room. These included age (per year older); gender
(female vs. male); Aboriginal Ancestry (yes vs. no); lim-
ited access to private space, as defined above (yes vs.
no); drug scene exposure, defined as spending an aver-
age of seven or more hours on the street each day in
Vancouver’s drug use epicentre in the previous six
months (yes vs. no); most drug use in public areas,
defined based on reports that public locations were
w h e r et h e ym o s tf r e q u e n t l yu s e dd r u g s( y e sv s .n o ) ;
daily crack cocaine smoking (yes vs. no); risky pipe shar-
ing, defined as reporting sharing a crack pipe or mouth-
piece in the same six month period as having burns or
sores on their mouth (yes vs. no); encounters with
police in the last month (yes vs. no); and being a victim
of violence (yes vs. no). As above, unless otherwise sta-
ted, all drug use and behavioural variables refer to the
previous six month period.
For both of our first and second analyses, we used
univariate and multivariate statistics to determine fac-
tors associated with our outcomes of interest. In uni-
variate analysis categorical explanatory variables were
analyzed using Pearson’s chi-square test and continuous
variables were analyzed using the Wilcoxon rank sum
test. Fisher’se x a c tt e s tw a su s e dw h e no n eo rm o r eo f
the cell counts was less than or equal to five. To evalu-
ate factors independently associated with our outcomes
of interest, all variables that were p < 0.05 in univariate
analyses were entered into the respective multivariate
regression models. All statistical analyses were per-
formed using SAS software version 9.1 (SAS, Cary, NC).
All p-values are two sided.
Results
During the study period 623 participants were seen for
study follow-up visits and reported smoking crack
cocaine in the last six months. These included 249
(40%) women and 231 (37%) persons who identified as
Aboriginal. The median number of times that partici-
pants reported smoking crack cocaine in an average day
was 4 (interquartile range = 2-10). Among our sample
of 623 crack smokers, a total of 382 (61%) reported
using in public areas in the last six months. The charac-
teristics of the study sample stratified by public drug use
are presented in Table 1, and the univariate analyses of
behavioral and socio-demographic variables associated
with public drug use among crack cocaine smokers are
presented in Table 2. The results of the multivariate
logistic regression for factors associated with public
drug use among crack cocaine smokers are also shown
in Table 2. Factors that remained independently asso-
ciated with our outcome of interest included: daily
heroin injection, daily crack cocaine smoking, encoun-
ters with police and drug dealing (see Table 2).
For our second analysis, the demographic and beha-
vioural characteristics of public crack cocaine smokers
stratified by willingness to use a supervised inhalation
room are presented in Table 3, and the univariate
results of factors associated with willingness to use a
Table 1 Characteristics of crack cocaine smokers
stratified by public drug use (n = 623)
Public drug use
a
Characteristic Yes n= 382,
n (%)
No n= 241,
n (%)
Age pre year older
(Median, IQR)
c 43 (37-49) 46 (40-50)
Female Gender
Yes 145 (38) 104 (43)
No 237 (62) 137 (57)
Aboriginal Ancestry
Yes 137 (36) 94 (39)
No 245 (64) 147 (61)
Limited Access to Private
Space
d
Yes 316 (83) 169 (70)
No 66 (17) 72 (30)
Daily Cocaine Injection
d
Yes 39 (10) 9 (4)
No 343 (90) 232 (96)
Daily Heroin Injection
d
Yes 107(28) 25 (10)
No 275 (72) 216 (90)
Daily Crack Smoking
d
Yes 220 (58) 72 (30)
No 162 (42) 169 (70)
Overdose (non-fatal)
d
Yes 18 (5) 3 (1)
No 364 (95) 238 (99)
Encounters with police
e
Yes 114 (30) 35 (15)
No 268 (70) 206 (85)
Victim of Violence
d
Yes 77 (20) 30 (12)
No 305 (80) 211 (88)
Sex Trade
d
Yes 60 (16) 19 (8)
No 322 (84) 222 (92)
Drug Dealing
d
Yes 150 (39) 46 (19)
No 232 (61) 195 (81)
Note:
a Public locations include: city streets, parks, public washrooms, parking
lots, clubs or bars, and abandon buildings;
c IQR = Inter Quartile Range;
d
Denotes activities or situations referring to previous 6 months;
e Denotes
activities or situations referring to previous month.
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T h er e s u l t so ft h em u l t i v a r i a t el o g i s t i cr e g r e s s i o nf o r
factors associated with willingness to use a supervised
inhalation room are also shown in Table 4. Factors that
remained independently associated with willingness
included: female gender, risky pipe sharing and recent
encounters with police (see Table 4.).
Discussion
We found that the majority of crack cocaine smokers
in our study reported having used drugs in public
areas at some point in the last six months. This group
was more likely to be higher-intensity drug users with
respect to heroin injection and crack cocaine smoking,
have encounters with the police and be involved in
drug dealing. Of these public crack cocaine smokers,
71% reported being willing to use a supervised inhala-
tion room if one was available. Individuals who
reported being willing were more likely to be female,
engage in risky pipe sharing and have encounters with
the police.
The profile of public crack cocaine smokers as higher-
intensity drug users who have interactions with the
criminal justice system is reflective of previous findings
describing public injection drug user populations [1,5].
The association between drug dealing and public crack
use may reflect the increased amount of time individuals
spend on the street when engaged in street-level drug
dealing. It may also be a function of the accessibility of
drugs and additional resources gained through drug
dealing which may lead to greater drug consumption
and hence a greater likelihood for consuming in public
areas [23].
Our finding that 71% of public crack cocaine smokers
are willing to use an inhalation facility also supports pre-
vious willingness estimates conducted among the general
population of Vancouver-based illicit drug users and sug-
gests that an intervention of this nature will likely reach
the target population [36]. The high degree of willingness
that this study found among public crack cocaine smo-
kers to use an inhalation facility suggests that, like super-
vised injection facilities, these interventions are likely to
Table 2 Univariate and multivariate analyses of factors associated with public drug use among crack cocaine smokers
a
(n = 623)
Univariate Multivariate
Characteristic OR
b (95% CI) p-value
c AOR (95% CI) p-value
Older Age
Per year older 0.96 (0.94 - 0.98) <0.001 0.98 (0.96 - 1.00) 0.065
Gender
Female vs. Male 0.81 (0.58 - 1.12) 0.197
Aboriginal Ancestry
Yes vs. No 0.87 (0.63 - 1.22) 0.429
Limited Access to Private Space
d
Yes vs. No 2.04 (1.39 - 2.99) <0.001 1.49 (0.99 - 2.26) 0.058
Daily Cocaine Injection
d
Yes vs. No 2.93 (1.39 - 6.17) 0.003 1.70 (0.77 - 3.75) 0.190
Daily Heroin Injection
d
Yes vs. No 3.36 (2.10 - 5.38) <0.001 1.95 (1.17 - 3.27) 0.011
Daily Crack Cocaine Smoking
d
Yes vs. No 3.19 (2.26 - 4.49) <0.001 2.17 (1.49 - 3.14) <.001
Overdose (non-fatal)*
d
Yes vs. No 3.92 (1.13 - 20.98) 0.020 2.04 (0.55 - 7.61) 0.288
Encounters with Police
e
Yes vs. No 2.50 (1.64 - 3.81) <0.001 1.69 (1.07 - 2.68) 0.025
Victim of Violence
d
Yes vs. No 1.78 (1.12 - 2.80) 0.013 1.52 (0.92 - 2.51) 0.100
Sex Trade
d
Yes vs. No 2.18 (1.26 - 3.75) 0.004 1.30 (0.72 - 2.38) 0.386
Drug Dealing
d
Yes vs. No 2.74 (1.87 - 4.01) <0.001 1.61 (1.06 - 2.47) 0.027
Note:
a Public areas included: city streets, parks, public washrooms, parking lots, clubs or bars, and abandon buildings;
bOR = Odds Ratio, CI = Confidence
Interval; AOR = Adjusted Odds Ratio;
cUnless otherwise stated, values are based on Pearson’s chi-square test for categorical variables and Wilcoxon rank sum test
for continuous variables with 1 degree of freedom;
d Denotes activities or situations referring to previous 6 months;
e Denotes activities or situations referring to
previous month. *p-value and 95% CI reported from Fisher’s Exact Test as 25% of cells had expected counts less than 5.
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indoor venues.
The increased likelihood of being willing to use an
inhalation facility among female participants may reflect
heightened vulnerability of women involved in street
drug use and it is noteworthy that Vancouver’ss u p e r -
vised injection facility has had success in attracting vul-
nerable female drug users and providing them with safer
alternatives to street-based drug using venues. In pre-
vious research female IDU have described the unique
role that Vancouver’s supervised injection facility has
played in promoting their physical security and health
safety [42].
Interestingly, one of the common features among both
public crack cocaine smokers and those who are willing
to use a supervised inhalation facility is their elevated
likelihood of recently having encounters with law enfor-
cement. This suggests that public crack cocaine smokers
who are the subject of law enforcement attention are
very willing to relocate to alternative off-street and
health-focussed environments if they were made avail-
able. Indeed, our data indicate that 81% of public crack
cocaine smokers who have had a recent encounter with
police are willing to use a supervised inhalation facility.
A key implication of these findings is that there is a
large demand for supervised inhalation rooms among
individuals that are potentially key contributors to drug-
related street disorder. The association between public
crack smoking and encounters with police suggests that
interventions of this nature are likely to target a critical
sub-population of drug users and could be a valuable
tool for police in the management of street disorder.
Previous studies have found that Vancouver police regu-
larly refer public injection drug users to the local super-
vised injection facility [43]. Since our analysis indicates
that local police are already frequently interacting with
public crack smokers the establishment of a supervised
inhalation facility could provide a unique opportunity
for police to direct this vulnerable group to a low-
t h r e s h o l ds e r v i c ew h e r et h e yw i l lh a v eo p p o r t u n i t i e st o
be linked with appropriate health and social services.
It is critical to note that although this study suggests
that supervised inhalation facilities could aid in the
reduction of public disorder, drug consumption facilities
do not address the route causes of street disorder and
are not appropriate substitutes for other essential health
and social interventions such as supportive housing and
addiction treatment. To be effective supervised inhala-
tion facilities should be integrated into broader compre-
hensive approaches to addressing the problems
associated with illicit drug addiction.
This study has a number of limitations. Firstly, VIDUS
is a community recruited non-randomized sample and
therefore our findings may not be generalizable to other
settings. If supervised inhalation facilities are being con-
sidered in other settings, willingness studies should be
conducted among the local target population and should
not rely on the findings emerging from our setting. The
generalizability of our findings is also limited by our
study sample which was restricted to individuals with a
history of injection drug use. Crack cocaine smokers
who did not have a history of injection drug use were
not eligible for our study. Given the harms associated
with injection drug use we anticipate that if a selection
Table 3 Characteristics of crack cocaine smokers who use
drugs in public stratified by willingness to use a
supervised inhalation room (n = 382)
Willing to use SIR
a
Characteristic Yes n= 271,
n (%)
No n= 111,
n (%)
Age pre year older
(Median, IQR)
c 43 (37-49) 44 (37-48)
Female Gender
Yes 117 (43) 28 (25)
No 154 (57) 83 (75)
Aboriginal Ancestry
Yes 108 (40) 29 (26)
No 163 (60) 82 (74)
Limited Access to Private
Space
e
Yes 230 (85) 86 (77)
No 41 (15) 25 (23)
Drug Scene Exposure
e, f
Yes 157 (58) 49 (44)
No 114 (42) 62 (56)
Most Drug Use in Public Areas
e
Yes 140 (52) 43 (39)
No 131 (48) 68 (61)
Daily Crack Cocaine Smoking
e
Yes 164 (61) 56 (50)
No 107 (39) 55 (50)
Risky Pipe Sharing
e
Yes 38 (14) 3 (3)
No 233 (86) 108 (97)
Encounters with Police
d
Yes 92 (34) 22 (20)
No 179 (66) 89 (80)
Victim of Violence
e
Yes 53 (20) 24 (22)
No 218 (80) 87 (78)
Note:
c IQR = Inter Quartile Range;
d Denotes activities or situations referring
to previous 6 months;
e Denotes activities or situations referring to previous
month;
f Drug scene exposure was defined as spending an average of 7 or
more hours on the street each day in Vancouver’s drug use epicenter in the
previous six months.
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towards high risk drug users, suggesting that this group
would be an appropriate target population for public
health intervention. We should also note that among
our study sample daily crack cocaine smoking was sig-
nificantly more common than daily injecting, suggesting
that despite the requirement of a history of injecting,
our sample represents a primarily crack cocaine smok-
ing population. Secondly, some of our measures relied
on self-report and could be vulnerable to socially desir-
able reporting. This would have likely been of most rele-
vant to our measure of willingness, since respondents
might perceive a pressure to report being willing to
engage with low-threshold services of this nature given
the widespread activism among local drug users in our
study setting to implement supervised drug consump-
tion facilities [32]. While it is possible that some respon-
dents may over-report willingness, a previous study
comparing measures of willingness to use a supervised
injection facility before it was established with later
reports of actual attendance after an injection facility
was established suggests that willingness measures are
good predictors of later behaviour among this
population [44]. Lastly, socially desirable reporting could
have influenced reports of stigmatized behaviour, such
as public drug use leading to an underestimation of
public crack smoking. If social desirability was an issue
in our study we suspect our finding would be a conser-
vative indication of the prevalence of and harms asso-
ciated with public drug use among crack cocaine
smokers.
In summary, our study found that locally public crack
smoking is a common practice that is also associated
with recent encounters with police. We found that the
majority of public crack smokers were willing to use an
inhalation facility if one were available. Furthermore,
public crack smokers who had recent encounters with
police were even more likely to be willing to use an
inhalation room, suggesting that supervised inhalation
facilities may offer unique opportunities to decrease one
component of drug-related street disorder and reduce
the burden on local law enforcement agencies.
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